483 Patheon Pharmaceuticals Mar 2017

483 Patheon Pharmaceuticals Mar 2017

Kenneth Felkley FDA$119.00 - Available Now

FDA investigators audited the Patheon Pharmaceuticals - Cincinnati, OH, United States facility and issued inspectional observations (via FDA 483) on 02 Mar 2017.

Product details

  • Category: Human Drugs
  • Inspection end: 02 Mar 2017
  • Location: Cincinnati, United States
  • FEI: 1510437
Add To Cart